NASDAQ$EKSO
Ekso Bionics Holdings Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Ekso Bionics reported a 38% year-over-year revenue increase and achieved a record quarter of EVO unit sales.
Ekso Bionics reported a strong third quarter with a 38% increase in revenue, reaching $4.6 million, driven by solid sales of EksoHealth devices and a record number of EVO unit sales. The company's gross profit also increased by 46% to $2.5 million, with a gross margin of approximately 53%.
- Reported revenue of $4.6 million in Q3 2023, a 38% increase year-over-year.
- Sold a total of 41 EksoHealth devices in Q3 2023.
- Achieved a record quarter of EVO unit sales.
- Gross profit of $2.5 million in Q3 2023, compared to $1.7 million in the same period last year.
Headline financials
Revenue & EPS history
Ekso Bionics · Revenue · Quarterly
$4.61M
Forward guidance
Ekso Bionics anticipates potential market expansion for home and community devices for spinal cord injury patients, pending CMS rule changes and application approval.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2023
-4.1%
Avg return
Earnings day
-1.6%
Avg return
5 days after
-4.0%
Avg return
30 days after
23%
11 / 47 earnings
Positive
+31.9%
Q2 2018
Best reaction
-27.4%
Q2 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | — | — | — | |
| Q3 2025 | -2.2% | +9.6% | -9.1% | |
| Q2 2025 | -27.4% | -23.0% | -14.1% | |
| Q1 2025 | -9.1% | -10.4% | -39.7% | |
| Q4 2024 | -1.2% | -19.9% | -13.2% | |
| Q3 2024 | -7.7% | -14.7% | -36.2% | |
| Q2 2024 | -9.1% | -9.2% | +25.0% | |
| Q1 2024 | -0.8% | +4.8% | -5.2% | |
| Q4 2023 | -20.6% | -22.6% | -27.6% | |
| Q3 2023 | -0.2% | +36.2% | +100.0% | |
| Q2 2023 | -5.6% | -11.2% | -24.5% | |
| Q1 2023 | +6.4% | +3.6% | +0.0% | |
| Q4 2022 | -4.5% | +7.1% | -6.5% | |
| Q3 2022 | -9.8% | -6.7% | -25.1% | |
| Q2 2022 | +2.9% | +7.0% | +37.4% | |
| Q1 2022 | -7.3% | -4.9% | -24.9% | |
| Q4 2021 | +6.6% | +7.9% | +26.6% | |
| Q3 2021 | +8.1% | +7.1% | -18.9% | |
| Q2 2021 | -0.2% | +4.3% | -4.3% | |
| Q1 2021 | +2.1% | -1.8% | +2.2% | |
| Q4 2020 | -10.2% | -8.8% | -21.9% | |
| Q3 2020 | -1.7% | +0.5% | +38.2% | |
| Q2 2020 | -10.9% | -13.4% | -30.2% | |
| Q1 2020 | -4.5% | -8.1% | -3.3% | |
| Q4 2019 | -19.5% | -13.7% | -32.9% | |
| Q3 2019 | -7.1% | -12.9% | -18.0% | |
| Q2 2019 | -21.2% | -23.0% | -45.1% | |
| Q1 2019 | -3.2% | -4.1% | -39.5% | |
| Q4 2018 | -0.9% | +2.1% | +7.7% | |
| Q3 2018 | +1.4% | +1.9% | -14.5% | |
| Q2 2018 | +31.9% | +44.5% | +34.1% | |
| Q1 2018 | -6.8% | -9.7% | +3.4% | |
| Q4 2017 | -13.7% | -13.1% | -10.9% | |
| Q3 2017 | -6.3% | +80.4% | +145.5% | |
| Q2 2017 | -1.6% | -1.3% | -21.4% | |
| Q1 2017 | -19.5% | -36.3% | -53.5% | |
| Q4 2016 | +0.6% | -6.1% | +0.0% | |
| Q3 2016 | +4.2% | +0.2% | +7.8% | |
| Q2 2016 | -3.1% | -2.8% | -39.5% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | -1.2% | — | — | |
| Q3 2015 | -2.6% | — | — | |
| Q2 2015 | -3.6% | — | — | |
| Q1 2015 | -9.6% | — | — | |
| Q4 2014 | +1.2% | — | — | |
| Q3 2014 | +10.4% | — | — | |
| Q2 2014 | -10.4% | — | — | |
| Q1 2014 | -1.8% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro